Cite
APA Citation
Masters, J. C., Khandelwal, A., di Pietro, A., Dai, H., & Brar, S. (2022). model‐informed drug development supporting the approval of the avelumab flat‐dose regimen in patients with advanced renal cell carcinoma. CPT: pharmacometrics & systems pharmacology, 11, 458–468. http://access.bl.uk/ark:/81055/vdc_100153772000.0x000004